←Back to Expert Scholars
Translational Medicine / 转化医学GI Precision Oncology
Kanwal Raghav
MD
🏢MD Anderson Cancer Center🌐USA
Associate Professor GI Medical Oncology
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Kanwal Raghav leads GI precision oncology efforts at MD Anderson and has contributed to HER2 and other biomarker directed trials in colorectal and appendiceal cancer. His work integrates molecular tumor board recommendations into GI trial strategy. He has advanced rare GI cancer precision medicine.
Share:
🧪Research Fields 研究领域
GI cancer
precision oncology
HER2 colorectal
appendiceal cancer
molecular tumor board
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Kanwal Raghav 的研究动态
Follow Kanwal Raghav's research updates
留下邮箱，当我们发布与 Kanwal Raghav（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment